Literature DB >> 26105759

Comparison of pulsatile and static pressures within the intracranial and lumbar compartments in patients with Chiari malformation type 1: a prospective observational study.

Radek Frič1, Per Kristian Eide.   

Abstract

BACKGROUND: In Chiari malformation type 1 (CMI), the obstruction of cerebrospinal fluid (CSF) flow through the foramen magnum is believed to cause alterations of intracranial pressure (ICP) pulsations. Foramen magnum decompression (FMD) is therefore considered a treatment of choice. However, the pathophysiology of CMI is poorly understood and it remains unknown how ICP alterations relate to symptoms and radiological findings. This study was undertaken to measure pulsatile pressure and its gradient between intracranial and lumbar compartments, and to determine its relationship to clinical and radiological findings.
METHOD: In patients with symptomatic CMI, we simultaneously measured ICP and lumbar CSF pressure, with particular focus on analysis of pulsatile pressure. Ventricular CSF volume (VV), intracranial volume (ICV) and posterior cranial fossa volume (PCFV) were calculated using volumetry software.
RESULTS: In 26 patients (median 35 years), we found clearly abnormal or borderline values of pulsatile ICP in 18/26 patients (69 %; median 4.5 mmHg) and abnormal pulsatile pressure gradient in 17/24 patients (71 %; median 2.6 mmHg). The correlation between pulsatile ICP and the pulsatile pressure gradient was significantly positive (p < 0.001). We found no significant correlation between pulsatile or static pressure and extent of tonsillar ectopy, VV, ICV or PCFV. The pulsatile pressure gradient was significantly higher in patients with syringomyelia (p = 0.02).
CONCLUSIONS: In this cohort, the pulsatile ICP was elevated in 69 %. The intracranial-lumbar pulsatile pressure gradient was abnormal in 71 % and significantly higher in patients with syringomyelia. The elevated pulsatile ICP significantly correlated with pulsatile pressure gradient; no similar correlation was found for static ICP. We interpret the results as providing evidence of impaired intracranial compliance as an important pathophysiological mechanism in CMI.

Entities:  

Mesh:

Year:  2015        PMID: 26105759     DOI: 10.1007/s00701-015-2465-x

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  6 in total

1.  Chiari 1 malformation and raised intracranial pressure.

Authors:  Rory J Piper; Shailendra A Magdum
Journal:  Childs Nerv Syst       Date:  2019-06-13       Impact factor: 1.475

Review 2.  Non-traumatic pediatric intracranial hypertension: key points for different etiologies, diagnosis, and treatment.

Authors:  Nir Shimony; Meleine Martinez-Sosa; Brooks Osburn; George I Jallo
Journal:  Acta Neurol Belg       Date:  2021-04-07       Impact factor: 2.396

3.  Computational Investigation of Cerebrospinal Fluid Dynamics in the Posterior Cranial Fossa and Cervical Subarachnoid Space in Patients with Chiari I Malformation.

Authors:  Karen-Helene Støverud; Hans Petter Langtangen; Geir Andre Ringstad; Per Kristian Eide; Kent-Andre Mardal
Journal:  PLoS One       Date:  2016-10-11       Impact factor: 3.240

4.  Intraparenchymal intracranial pressure monitoring for hydrocephalus and cerebrospinal fluid disorders.

Authors:  Aswin Chari; Debayan Dasgupta; Alexander Smedley; Claudia Craven; Edward Dyson; Samir Matloob; Simon Thompson; Lewis Thorne; Ahmed K Toma; Laurence Watkins
Journal:  Acta Neurochir (Wien)       Date:  2017-08-10       Impact factor: 2.216

5.  Cardiovascular risk factors in Chiari malformation and idiopathic intracranial hypertension.

Authors:  Radek Frič; Are Hugo Pripp; Per Kristian Eide
Journal:  Brain Behav       Date:  2017-03-28       Impact factor: 2.708

6.  Non-invasive assessment of pulsatile intracranial pressure with phase-contrast magnetic resonance imaging.

Authors:  Geir Ringstad; Erika Kristina Lindstrøm; Svein Are Sirirud Vatnehol; Kent-André Mardal; Kyrre Eeg Emblem; Per Kristian Eide
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.